Welcome to Eubelius | Eubelius

Jump to navigation

Biotechnology: Eubelius assists Graftys Belgium in its EUR 4.1 million capital increase

Graftys Belgium, an innovative biotechnology company specialising in synthetic resorbable bone cements and based in...

Eubelius assists the shareholders with the sale of the Power fuel group to Gabriëls

Eubelius recently assisted the shareholders of the Power fuel group in connection with the sale of the Power Group to...

14 February 2019

Eubelius clients prevail before EU General Court in “Excess Profit Rulings” matter

On 14 February 2019 the EU General Court delivered its judgment in what is known as the “Belgian excess profit rulings...

31 January 2019

Proximus, represented by Eubelius, wins class action proceedings against consumer organisation Test-Aankoop/Test-Achats

In a judgment dated 30 January 2019, the Brussels Court of Appeal has rejected the first big class action under Belgian...

25 January 2019

Recent developments in intellectual property and trade secrets

Yesterday Eubelius organised its first client seminar of the year, with 100 participants.

All content on our website, including the printed version thereof, is subject to the Terms of Use available on the website.